Oncología Traslacional
ONCTRAS
Centre Hospitalier Universitaire de Liège
Lieja, BélgicaPublicacións en colaboración con investigadores/as de Centre Hospitalier Universitaire de Liège (5)
2024
-
SENECA study: staging endometrial cancer based on molecular classification
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, Vol. 34, Núm. 9, pp. 1313-1321
-
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
New England Journal of Medicine, Vol. 391, Núm. 1, pp. 44-55
2022
-
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
The Lancet Oncology, Vol. 23, Núm. 8, pp. e374-e384
2021
-
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
The Lancet. Oncology, Vol. 22, Núm. 5, pp. 609-619
2020
-
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer
International Journal of Cancer, Vol. 146, Núm. 2, pp. 439-448